← Back to Clinical Trials
Recruiting NCT06938308

NCT06938308 Comparison Between the I-gel and Protector Supraglottic Airway Devices

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06938308
Status Recruiting
Phase
Sponsor Nikolopoulou Maria Zozefin
Condition Airway Management
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2025-04-22
Primary Completion 2025-09-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 90 Years
Study Type INTERVENTIONAL
Interventions
LMA IgelLMA Protector

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2025-04-22 with a primary completion date of 2025-09-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare the learning curves of two different laryngeal mask airway devices, by evaluating their placement in adult patients performed by anesthesiology residents

Eligibility Criteria

Inclusion Criteria: * ASA I-II * Patients older than 18 years * Procedures in supine and lithotomy position Exclusion Criteria: * Tumors or anatomical anomalies of the upper airway * Known history of difficult intubation * Limited mouth opening less than 2cm * Decreased compliance of the lungs or the thoracic cage * Need of mechanical ventilation after the surgery

Contact & Investigator

Central Contact

Maria Zozefin Nikolopoulou

✉ mz.nikolopoulou@gmail.com

📞 +306987389354

Frequently Asked Questions

Who can join the NCT06938308 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Airway Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06938308 currently recruiting?

Yes, NCT06938308 is actively recruiting participants. Contact the research team at mz.nikolopoulou@gmail.com for enrollment information.

Where is the NCT06938308 trial being conducted?

This trial is being conducted at Athens, Greece.

Who is sponsoring the NCT06938308 clinical trial?

NCT06938308 is sponsored by Nikolopoulou Maria Zozefin. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology